DrugInformations.org

Diabetes UK has launched a lively and informative webspace for professional members on our award-winning website. The new password protected area is an exciting addition to the professional membership benefits package and offers an exclusive access to a range of resources. These include regular news updates, referenced articles and information tailored to specific disciplines - a definitive diabetes resource to help professional members stay informed.

More: continued here

No Comments »

ORLANDO, FL (UroToday.com) - Researchers from the University of Tennessee in Memphis in a retrospective case control study of 713 consecutive patients treated with SWL and 146 consecutive patients treated with ueteroscopy (URS) analyzed demographic, laterality of the stone burden and treatment modality, and presence of pre-operative and post-operative diabetes mellitus to determine any significant relationships. Of the 713 SWL patients 137 had pre-existing diabetes mellitus.

More: continued here

No Comments »

Pastillas para la diabetes tipo 2, a new consumer guide for Hispanic adults who have type 2 diabetes and need information to help them compare various oral medications for their illness, has been released by the Agency for Healthcare Research and Quality. Diabetes is one of the most serious health issues facing Hispanics in the United States. AHRQ data show that nearly one in eight Hispanics take a prescription drug for diabetes.

More: continued here

No Comments »

Osiris Therapeutics, Inc. (NASDAQ:OSIR) announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation (JDRF) for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for patients recently diagnosed with type 1 diabetes. The payments were triggered when Osiris accomplished certain clinical and regulatory milestones including initiating patient treatments.

More: continued here

No Comments »

Researchers at UT Southwestern Medical Center have determined that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span. “It’s been well-established that growth is blunted during starvation. But our work shows that this is not just from running out of energy. It’s much more sophisticated than that,” said

More: continued here

No Comments »

A gifted dance student is being denied the chance to fulfil a life-long ambition to go professional as he cannot afford his dance school fees and has turned to Diabetes UK for help. Callum Daly, 19, who has Type 1 diabetes, passed a tough audition last year for a place on a year-long foundation course at the prestigious ‘Performers College’ in Essex.

More: continued here

No Comments »

Turmeric, an Asian spice found in many curries, has a long history of use in reducing inflammation, healing wounds and relieving pain, but can it prevent diabetes? Since inflammation plays a big role in many diseases and is believed to be involved in onset of both obesity and Type 2 diabetes, Drew Tortoriello, M.D.

More: continued here

No Comments »

One-third of Hispanic women with diabetes living in Connecticut have never seen a registered dietitian or diabetes health educator, and nutrition knowledge was limited even among those who had, according to a study in the June issue of the Journal of the American Dietetic Association, Reuters Health reports.

More: continued here

No Comments »

Diabetes UK has become the first charity in the UK to create an Equality and Diversity team. The team is dedicated to helping diverse groups including black, Asian and minority ethnic communities, people with learning disabilities, prisoners and gypsies. The team includes four Diverse Community Officers (DCOs) who each cover London, the South East, West Midlands and the North West and are led by Diabetes UK Equality and Diversity Manager Jenne Dixit.

More: continued here

No Comments »

It is estimated that diabetes affects more than 18 million people in the United States and approximately 194 million adults worldwide. The World Health Organization projects that the number of people with diabetes will double to 366 million by 2030, presenting a lucrative commercial opportunity to drug development companies.

More: continued here

No Comments »